Status:

WITHDRAWN

Transitioning to a Valve -Gated Intrathecal Drug Delivery System (IDDS)

Lead Sponsor:

Rush University Medical Center

Collaborating Sponsors:

Flowonix Medical

Conditions:

Chronic Pain

Intractable Pain

Eligibility:

All Genders

22-85 years

Phase:

PHASE4

Brief Summary

Flowonix Prometra® II Programmable Pump may require a smaller dose of drug when converting from other commercially available intrathecal drug delivery systems (IDDS).

Detailed Description

This open-label, non-randomized, single-blind, multi-center study is designed to evaluate effects of a planned 20% dose reduction when converting to valve-gated from a peristaltic pump. Study particip...

Eligibility Criteria

Inclusion

  • Be male or female between the ages of 22 and 85 years
  • Be capable of giving informed consent and completing assessments required by the study
  • Have pain intensity of greater than 5 out of 10 as measured by VAS
  • Have an active existing peristaltic intrathecal drug delivery system
  • Have stable drug dosage for at least 6 weeks prior to valve-gated pump implant
  • Be an appropriate candidate for surgery
  • Be able to comply with required study visits and assessments including English proficiency

Exclusion

  • Have a significant pain disorder not intended to be treated with the test device or comparator
  • Be terminally ill and/or have a life expectancy of less than 6 months
  • Be a pregnant/lactating woman or a woman of child-bearing potential
  • Have a systemic or local infection (contraindicated for pump implantation)
  • Have history/evidence of an active disruptive psychiatric disorder or other known condition with potential to impact compliance with study visits and assessments
  • Have an underlying condition increasing susceptibility to infection

Key Trial Info

Start Date :

October 1 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 1 2022

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT03876158

Start Date

October 1 2019

End Date

June 1 2022

Last Update

March 12 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Rush University Medical Center Pain Center

Chicago, Illinois, United States, 60612